GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
Details for Australian Patent Application No. 2002322430 (hide)
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 60/328,507 10.10.01 US; 60/305,016 12.07.01 US
22 May 2003 Application Open to Public Inspection
Published as AU-A-2002322430
6 May 2004 Amendment Made
The nature of the amendment is: Add the co-inventor Roche, Siobhan 2002322527 CV Therapeutics, Inc. The nature of the amendment is as shown in the statement(s) filed 06 Apr 2004
9 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002322431-DIRECTIONAL SOUND ACQUISITION
2002322429-USE OF MATRIX METALLOPROTEINASE INHIBITORS TO MITIGATE NERVE DAMAGE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser